CompoAtlas

Magnesium Malate

Natural health product licensed in Canada

Licence holder
New Nordic Inc.
NPN or DIN-HM
80113633
Status
Active licence
Licence date
21 October 2021
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine D

Source : Cholécalciférol

3.3 microgram6.6 µg
Pinus pinaster

Source : Écorce (tige)

Extract : Matériel brut sec

Extraction ratio : 6:1:12:1

Dry plant equivalent : 60-120 mg

Potency : 40 % Proanthocyanidins

10 mgNot calculated
Magnésium

Source : Malate de magnésium

77.6 mg155,200 µg

Non-medicinal ingredients

Silice, Glycérine, Stéarate de magnésium, Hypromellose, Cellulose, Poivre long

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years2 Comprimé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps in energy metabolism in the body. Helps to form red blood cells. Helps to maintain normal electrolyte balance. Contributes to the normal function of the nervous system. Helps to maintain proper muscle function (including the heart muscle).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80113633

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line